Total Payments
$1.2M
2024 Payments
$261,448
Companies
33
Transactions
2,309
Medicare Patients
3,481
Medicare Billing
$770,401
Payment Breakdown by Category
Other$968,810 (79.8%)
Travel$109,968 (9.1%)
Consulting$87,109 (7.2%)
Food & Beverage$47,496 (3.9%)
Education$934.69 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $967,550 | 375 | 79.7% |
| Travel and Lodging | $109,968 | 502 | 9.1% |
| Consulting Fee | $87,109 | 45 | 7.2% |
| Food and Beverage | $47,496 | 1,365 | 3.9% |
| Honoraria | $1,260 | 1 | 0.1% |
| Education | $934.69 | 21 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $408,176 | 701 | $0 (2024) |
| GENZYME CORPORATION | $244,759 | 353 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $213,933 | 330 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $170,299 | 310 | $0 (2023) |
| GlaxoSmithKline, LLC. | $89,024 | 179 | $0 (2024) |
| Genentech USA, Inc. | $55,463 | 157 | $0 (2024) |
| Amgen Inc. | $11,829 | 36 | $0 (2024) |
| PFIZER INC. | $7,115 | 35 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $6,075 | 66 | $0 (2024) |
| OptiNose US, Inc. | $3,003 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261,448 | 374 | AstraZeneca Pharmaceuticals LP ($156,644) |
| 2023 | $240,551 | 364 | AstraZeneca Pharmaceuticals LP ($101,573) |
| 2022 | $179,898 | 331 | AstraZeneca Pharmaceuticals LP ($68,145) |
| 2021 | $231,014 | 371 | Teva Pharmaceuticals USA, Inc. ($92,715) |
| 2020 | $79,815 | 182 | AstraZeneca Pharmaceuticals LP ($19,366) |
| 2019 | $159,559 | 352 | GENZYME CORPORATION ($67,550) |
| 2018 | $17,695 | 145 | Teva Pharmaceuticals USA, Inc. ($10,068) |
| 2017 | $44,337 | 190 | Teva Pharmaceuticals USA, Inc. ($42,862) |
All Payment Transactions
2,309 individual payment records from CMS Open Payments — Page 1 of 93
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,531.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $150.00 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Immunology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,465.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $596.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $194.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Immunology | ||||||
| 11/15/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $5,720.00 | General |
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $668.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $649.96 | General |
| 11/15/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $477.53 | General |
| 11/15/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $298.26 | General |
| 11/15/2024 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $91.56 | General |
| 11/15/2024 | GENZYME CORPORATION | — | Food and Beverage | Cash or cash equivalent | $25.60 | General |
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $275.83 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 899 | 16,882 | $726,873 | $278,195 |
| 2022 | 15 | 932 | 16,880 | $631,188 | $266,779 |
| 2021 | 15 | 779 | 10,979 | $293,795 | $112,639 |
| 2020 | 15 | 871 | 13,378 | $324,022 | $112,788 |
Total Patients
3,481
Total Services
58,119
Medicare Billing
$770,401
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 16 | 5,623 | $377,190 | $169,345 | 44.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 155 | 4,590 | $134,430 | $51,484 | 38.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 188 | 1,892 | $72,084 | $15,146 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 164 | $35,766 | $14,166 | 39.6% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 52 | 3,216 | $44,998 | $9,640 | 21.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $10,967 | $3,995 | 36.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 322 | $16,790 | $3,361 | 20.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 36 | 499 | $8,324 | $2,731 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $8,104 | $2,721 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 39 | $6,408 | $2,502 | 39.0% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 36 | 315 | $8,880 | $2,088 | 23.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $715.00 | $391.95 | 54.8% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 11 | 11 | $484.00 | $317.20 | 65.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 92 | 106 | $1,518 | $193.74 | 12.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 17 | $215.25 | $113.46 | 52.7% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 11 | 5,140 | $312,930 | $153,133 | 48.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 151 | 4,055 | $109,425 | $46,380 | 42.4% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 162 | 1,865 | $59,680 | $14,857 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 135 | 155 | $29,450 | $13,755 | 46.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 66 | 4,040 | $52,520 | $12,818 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $18,270 | $7,766 | 42.5% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 47 | 653 | $9,469 | $4,172 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 58 | $7,656 | $3,913 | 51.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $8,360 | $3,559 | 42.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 261 | $11,745 | $2,833 | 24.1% |
About Dr. Charles Lane, MD
Dr. Charles Lane, MD is a Allergy & Immunology healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1699983353.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Lane, MD has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $261,448 received in 2024. These payments were reported across 2,309 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($967,550).
As a Medicare-enrolled provider, Lane has provided services to 3,481 Medicare beneficiaries, totaling 58,119 services with total Medicare billing of $770,401. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Lynchburg, VA
- Active Since 05/18/2007
- Last Updated 01/13/2025
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1699983353
Products in Payments
- DUPIXENT (Biological) $344,492
- TEZSPIRE (Biological) $248,682
- NUCALA (Biological) $86,423
- DUPIXENT (Drug) $73,022
- FASENRA (Biological) $65,787
- Xolair (Biological) $55,679
- AIRSUPRA (Drug) $44,130
- AirDuo RespiClick (Drug) $43,180
- CINQAIR (Drug) $41,439
- FASENRA (Drug) $39,544
- CINQAIR (Biological) $34,032
- ArmonAir Digihaler (Drug) $23,363
- ProAir Digihaler (Drug) $14,158
- QVAR (Drug) $5,229
- Xhance (Drug) $3,003
- PROAIR (Drug) $2,257
- AIRDUO (Drug) $2,121
- AYVAKIT (Drug) $1,440
- RESLIZUMAB (Drug) $1,313
- SYMBICORT (Drug) $814.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.